BioSpace News Archive

Qiagen manufactures diagnostic tests for a variety of diseases including cancer and, currently, the coronavirus that causes COVID-19.

In addition, the company’s chief scientific officer, Seth Ettenberg, has resigned.

Polarean Imaging plc announces that it has issued 232,010 new ordinary shares of £0.00037 each in the capital of the Company at par value, following the exercise of warrants by Amphion Innovations plc.

According to recently published report by Future Market Insights, the global atopic dermatitis treatment market size is expected to reach US$ 26 Bn by 2029.

The report details an exhaustive account of the global healthcare chatbots market along with numerous associated factors.

The global healthcare sector is advancing at a rapid rate, as it is integrating advanced technologies and various software to simplify working in it.

This approval marks the first time in a decade Sanofi has had a wholly-owned cancer drug approved.

Ghosh succeeds current Unity CEO Keith Leonard, who will step down from his role. Leonard will continue as the chairman of the board of directors.

Acacia Pharma Group plc, a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures or cancer chemotherapy, announces the following changes to its Officers and Board of Directors.

Abpro to receive up to $1.1 billion, including a $30 million upfront equity investment, clinical funding, milestones, and royalties